Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | FPI-2053 |
| Trade Name | |
| Synonyms | FPI 2053|FPI2053 |
| Drug Descriptions |
FPI-2053 is a bispecific antibody targeting EGFR and MET (Mol Cancer Ther (2023) 22 (12_Supplement): A146). |
| DrugClasses | EGFR Antibody 73 MET Antibody 38 |
| CAS Registry Number | NA |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| FPI-2053 | FPI-2053 | 0 | 0 |
| FPI-2053 + FPI-2068 | FPI-2053 FPI-2068 | 0 | 1 |